BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2965311)

  • 1. Prostacyclin (epoprostenol) as the sole antithrombotic agent in postdilutional hemofiltration.
    Canaud B; Mion C; Arujo A; N'Guyen QV; Paleyrac G; Hemmendinger S; Cazenave JP
    Nephron; 1988; 48(3):206-12. PubMed ID: 2965311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation with prostacyclin and heparin during continuous venovenous hemofiltration.
    Langenecker SA; Felfernig M; Werba A; Mueller CM; Chiari A; Zimpfer M
    Crit Care Med; 1994 Nov; 22(11):1774-81. PubMed ID: 7956281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration.
    Kozek-Langenecker SA; Spiss CK; Michalek-Sauberer A; Felfernig M; Zimpfer M
    Crit Care Med; 2003 Mar; 31(3):864-8. PubMed ID: 12626998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo.
    Cadroy Y; Horbett TA; Hanson SR
    J Lab Clin Med; 1989 Apr; 113(4):436-48. PubMed ID: 2522978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin.
    Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
    Herz; 1986 Apr; 11(2):116-26. PubMed ID: 2939012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epoprostenol (PGI2, prostacyclin) during high-risk hemodialysis: preventing further bleeding complications.
    Swartz RD; Flamenbaum W; Dubrow A; Hall JC; Crow JW; Cato A
    J Clin Pharmacol; 1988 Sep; 28(9):818-25. PubMed ID: 3068260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo release and turnover of secreted platelet antiheparin proteins in rhesus monkey (Macaca mulatta).
    Musial J; Niewiarowski S; Edmunds LH; Addonizio VP; Nicolaou KC; Colman RW
    Blood; 1980 Oct; 56(4):596-607. PubMed ID: 6158350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a stable 5-F prostacyclin analogue as an antithrombotic agent in haemodialysis.
    Nicholson NS; Smith SL; Taite BB; Krueger A; Fuller GC
    Drugs Exp Clin Res; 1986; 12(5):371-5. PubMed ID: 3522158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the antithrombotic effects of heparin, enoxaparin and prostacycline in continuous hemofiltration].
    Journois D; Safran D; Castelain MH; Chanu D; Drévillon C; Barrier G
    Ann Fr Anesth Reanim; 1990; 9(4):331-7. PubMed ID: 2169213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of prostacyclin infusion on platelet hemostatic function in patients undergoing cardiopulmonary bypass.
    Malpass TW; Amory DW; Harker LA; Ivey TD; Williams DB
    J Thorac Cardiovasc Surg; 1984 Apr; 87(4):550-5. PubMed ID: 6231433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-mediated neutralization of platelet antiaggregatory activity of prostacyclin (PGI2): studies on mechanism.
    Saba SR; Saba HI
    Am J Hematol; 1985 Oct; 20(2):97-105. PubMed ID: 3898823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of PGI2 infusion during long term extracorporeal circulation with membrane lung in sheep.
    Uziel L; Agostoni A; Pirovano E; Pesenti A; Pelizzola A; Gattinoni L; Galmarini D
    Int J Artif Organs; 1981 May; 4(3):142-5. PubMed ID: 7024139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double blind study of prostacyclin in cardiopulmonary bypass surgery.
    Walker ID; Davidson JF; Faichney A; Wheatley DJ; Davidson KG
    Br J Haematol; 1981 Nov; 49(3):415-23. PubMed ID: 6457624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostacyclin and iloprost do not affect action of standard dose heparin on haemostatic function during haemodialysis.
    Dibble JB; Kalra PA; Orchard MA; Turney JH; Davies JA
    Thromb Res; 1988 Feb; 49(4):385-92. PubMed ID: 2454514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodialysis with prostacyclin (Epoprostenol) alone.
    Rylance PB; Gordge MP; Ireland H; Lane DA; Weston MJ
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():281-6. PubMed ID: 3887374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostacyclin is a more potent stimulator of thrombolysis than inhibitor of haemostasis.
    Görög P; Kovacs IB
    Haemostasis; 1986; 16(5):337-45. PubMed ID: 3536684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracorporeal left ventricular assistance with prostacyclin and heparinized centrifugal pump.
    Palatianos GM; Edmunds LH; Cohen DJ; Stephenson LW
    Ann Thorac Surg; 1983 May; 35(5):504-15. PubMed ID: 6342555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the effects of catheter sampling for the study of platelet behavior in the pulmonary and coronary circulation.
    Bugiardini R; Chierchia S; Crea F; Gallino A; Wild S; Roskovec A; Lenzi S; Maseri A
    Am Heart J; 1984 Aug; 108(2):255-60. PubMed ID: 6205577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet resistance to prostacyclin. Enhancement of the antiaggregatory effect of prostacyclin by pentoxifylline.
    Manrique RV; Manrique V
    Angiology; 1987 Feb; 38(2 Pt 1):101-8. PubMed ID: 3030162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular response during hemodialysis and hemofiltration: thermal, membrane, and catecholamine influences.
    Fox SD; Henderson LW
    Blood Purif; 1993; 11(4):224-36. PubMed ID: 8297564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.